Literature DB >> 10625307

Differentiation-inducing factor-1, a morphogen of dictyostelium, induces G(1) arrest and differentiation of vascular smooth muscle cells.

Y Miwa1, T Sasaguri, C Kosaka, Y Taba, A Ishida, T Abumiya, Y Kubohara.   

Abstract

Differentiation-inducing factor-1 (DIF-1) is a morphogen that induces differentiation of DICTYOSTELIUM: Recently, DIF-1 has been shown to inhibit proliferation and induce differentiation in tumor cells, although the underlying mechanisms remain unknown. In this study, we examined the effects of DIF-1 on the proliferation and differentiation of vascular smooth muscle cells, to explore novel therapeutic strategies for atherosclerosis. DIF-1 nearly completely inhibited DNA synthesis and cell division in mitogen-stimulated cells. DIF-1 inhibited the phosphorylation of the retinoblastoma protein and the activities of cyclin-dependent kinase (Cdk) 4, Cdk6, and Cdk2, which phosphorylate the retinoblastoma protein. DIF-1 strongly suppressed the expression of cyclins D1, D2, and D3, as well as those of cyclins E and A, which normally began after that of the D-type cyclins. The mRNAs for the smooth muscle myosin heavy chains SM1 and SM2 were expressed in quiescent cells in primary culture, and these expression levels decreased after mitogenic stimulation. In the presence of DIF-1, the rate of the reduction was significantly decelerated. Moreover, the addition of DIF-1 to dedifferentiated cells induced the expressions of SM1 and SM2, accompanied by a reduction in the level of SMemb, a nonmuscle-type myosin heavy chain. Therefore, DIF-1 seemed to interrupt a very early stage of G(1) probably by suppressing the expressions of the D-type cyclins. Furthermore, this compound may prevent phenotypic modulation and induce differentiation of vascular smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10625307     DOI: 10.1161/01.res.86.1.68

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  5 in total

1.  Br-DIF-1 accelerates dimethyl sulphoxide-induced differentiation of P19CL6 embryonic carcinoma cells into cardiomyocytes.

Authors:  K Seya; K Kanemaru; M Matsuki; K Hongo; H Kitahara; H Kikuchi; Y Oshima; Y Kubohara; K Okumura; S Motomura; K-I Furukawa
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

2.  Anti-angiogenic effects of differentiation-inducing factor-1 involving VEGFR-2 expression inhibition independent of the Wnt/β-catenin signaling pathway.

Authors:  Tatsuya Yoshihara; Fumi Takahashi-Yanaga; Fumie Shiraishi; Sachio Morimoto; Yutaka Watanabe; Masato Hirata; Sumio Hoka; Toshiyuki Sasaguri
Journal:  Mol Cancer       Date:  2010-09-16       Impact factor: 27.401

Review 3.  Dictyostelium: An Important Source of Structural and Functional Diversity in Drug Discovery.

Authors:  Yuzuru Kubohara; Haruhisa Kikuchi
Journal:  Cells       Date:  2018-12-21       Impact factor: 6.600

4.  Differentiation-inducing factor-1 suppresses cyclin D1-induced cell proliferation of MCF-7 breast cancer cells by inhibiting S6K-mediated signal transducer and activator of transcription 3 synthesis.

Authors:  Fumi Tetsuo; Masaki Arioka; Koichi Miura; Misato Kai; Momoko Kubo; Kazunobu Igawa; Katsuhiko Tomooka; Fumi Takahashi-Yanaga; Fusanori Nishimura; Toshiyuki Sasaguri
Journal:  Cancer Sci       Date:  2019-10-26       Impact factor: 6.716

5.  Mitochondria are the target organelle of differentiation-inducing factor-3, an anti-tumor agent isolated from Dictyostelium discoideum [corrected].

Authors:  Yuzuru Kubohara; Haruhisa Kikuchi; Yusuke Matsuo; Yoshiteru Oshima; Yoshimi Homma
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.